Expression levels of DNA methyltransferase genes do not correlate with p15INK4B gene methylation in myelodysplastic syndromes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

1. Expression Profiles of DNA Methylation and Demethylation Machinery Components in Pediatric Myelodysplastic Syndrome: Clinical Implications.Cancer management and research · 2020
   Article
2. DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma.Oncotarget · 2017
   Article
3. Reduced rRNA expression and increased rDNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes.Blood · 2012
   Article
4. hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing.The Journal of clinical investigation · 2010
   Article
5. DNA methyltransferase expression differs with proliferation in childhood acute lymphoblastic leukemia.Molecular biology reports · 2010
   Article
6. Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.International journal of hematology · 2004
   Review
7. Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?Leukemia · 2003
   Review

Corrections and comments

• Commented on by
  Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?2003
• Commented on by
  Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case.2003

Authors and funding

6 authors at 3 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as